Banking on hope, swayed by hype? Hydroxychloroquine in the time of Covid-19

Banking on hope, swayed by hype? Hydroxychloroquine in the time of Covid-19
As coronavirus deaths amassed and already stretched health care systems in Europe, and the United States groaned with the added weight of the pandemic, the FDA and EMA agencies adopted contradictory tones over the use of a pair of decades-old malaria drugs to fight the virus — epitomizing the desperation to combat an uncharted disease.

“This is just another example that points to the fact that while EMA and FDA oftentimes take the same position, they also take contrary positions,” said Peter Pitts, who served as the FDA’s associate commissioner for external relations between 2002 and 2004. “We are addressing Covid-19 in a variety of ways, and so is the EMA — the circles are concentric, but they are not identical.”
Sign Up for Our Email Newsletter

RECENT NEWS

Health care lessons ignored from our fight against COVID-19

Health care lessons ignored from our fight against COVID-19

The current problems we’re dealing with relative to vaccine roll-out remind us how much we have learned — and how little ...  Read more

U.K. Becomes First Country to Approve the Pfizer-BioNTech COVID-19 Vaccine, But the U.S. Is Close Behind

U.K. Becomes First Country to Approve the Pfizer-BioNTech COVID-19 Vaccine, But the U.S. Is Close Behind

The U.K. has become the first country to approve the Pfizer and BioNTech COVID-19 vaccine and will begin distributing dos...  Read more

How Covid Has Reframed the 5 Urgencies of 21st Century Healthcare

How Covid Has Reframed the 5 Urgencies of 21st Century Healthcare

...  Read more

DRUGWONKS BLOG